Botanical drug clinical trial: Common issues and future options
In order to understand this disparity between human use and drugs approved by regulatory agencies, we analyzed botanical drug clinical trials registered at ClinicalTrial.gov to detect trends in current trials and guide future trials. A total of 195 botanical drug clinical trials were registered from...
Main Authors: | Yu Sun, Jiahua Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383520306729 |
Similar Items
-
Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis
by: Svedbom A, et al.
Published: (2017-04-01) -
The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
by: Zhongwei Sha, et al.
Published: (2020-01-01) -
Defining key design elements of registry-based randomised controlled trials: a scoping review
by: Bill Karanatsios, et al.
Published: (2020-06-01) -
Effectiveness trials: critical data to help understand how respiratory medicines really work?
by: Andreas Heddini, et al.
Published: (2019-01-01) -
Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial
by: Yuyi Chen, et al.
Published: (2021-07-01)